Sign up
Quantellect · Congress · Trade Detail
NASDAQ: JAZZJazz Pharmaceuticals PLC
DemocratHouse

Daniel S. Goldman sold Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)

Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 3 trades in Jazz Pharmaceuticals PLC (JAZZ) since 2023, 1 purchase and 2 sales, worth an estimated $73K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Daniel S. Goldman sold $15,001 - $50,000 of Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) on July 12, 2023. Since that trade, JAZZ is up +104.29% against the S&P 500 up +69.33%, an outperformance of +34.96%.

Across these filings, Daniel S. Goldman has been a net seller of JAZZ (a buy-to-sell ratio of 0.50). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

JAZZ trades
3
Disclosed Vol
$73K
Buys
1
33%
Sells
2
67%
Buy / Sell
0.50
ratio
First → Last
2023

Daniel S. Goldman's JAZZ trades vs the price

JAZZ is up +104.29% since Daniel S. Goldman sold on July 12, 2023, versus +69.33% for the S&P 500.

Performance since this trade

Price change since trade
+104.29%
S&P 500 change since trade
+69.33%
Outperformance vs S&P 500
+34.96%

All Daniel S. Goldman JAZZ trades

TradedTypeSizeReturnEst. profit
July 12, 2023SELL$125.30+104.29%
March 6, 2023BUY$142.78+79.28%+$26K
January 31, 2023SELL$156.66+63.39%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Daniel S. Goldman & JAZZ trading FAQ

Is it legal for Daniel S. Goldman to trade Jazz Pharmaceuticals PLC (JAZZ) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Jazz Pharmaceuticals PLC (JAZZ), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Daniel S. Goldman sell JAZZ?

Daniel S. Goldman disclosed a sale of $15,001 - $50,000 of Jazz Pharmaceuticals PLC (JAZZ) on July 12, 2023, according to public STOCK Act filings.

How has JAZZ performed since Daniel S. Goldman's trade?

Since Daniel S. Goldman sold JAZZ on July 12, 2023, the stock is up +104.29%, versus +69.33% for the S&P 500 over the same period, an outperformance of +34.96%.

How many times has Daniel S. Goldman traded JAZZ?

Daniel S. Goldman has disclosed 3 JAZZ trades since 2023 (1 purchase and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional JAZZ trades?

Quantellect tracks every disclosed congressional trade in Jazz Pharmaceuticals PLC (JAZZ) on the Jazz Pharmaceuticals PLC congressional trading page, which aggregates filings across all members of Congress.

Daniel S. Goldman's JAZZ tradesAll congressional filings for Jazz Pharmaceuticals PLCDaniel S. Goldman's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.